Published in Lancet Infect Dis on August 01, 2005
A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis (2012) 2.09
Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission. PLoS Negl Trop Dis (2010) 1.65
The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis. Filaria J (2006) 1.54
Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation. Am J Trop Med Hyg (2008) 1.25
Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India. Bull World Health Organ (2007) 1.22
Neglected tropical diseases: survey and geometry of randomised evidence. BMJ (2012) 1.07
Mathematical models for lymphatic filariasis transmission and control: Challenges and prospects. Parasit Vectors (2008) 1.06
The impact of a filariasis control program on Lihir Island, Papua New Guinea. PLoS Negl Trop Dis (2011) 0.90
Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea. PLoS One (2013) 0.85
Prevention and control of neglected tropical diseases: overview of randomized trials, systematic reviews and meta-analyses. Bull World Health Organ (2014) 0.82
Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011. Parasit Vectors (2013) 0.81
An analysis of genetic diversity and inbreeding in Wuchereria bancrofti: implications for the spread and detection of drug resistance. PLoS Negl Trop Dis (2008) 0.80
Arbonematodes - nematode infections transmissible by arthropods: arbeitskreis blut, untergruppe «bewertung blutassoziierter krankheitserreger»*. Transfus Med Hemother (2013) 0.75
From red to white urine: a patient's nightmare with a rather benign outcome. BMC Nephrol (2012) 0.75
Lymphatic filariasis elimination efforts in Rufiji, South-Eastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long lasting insecticide treated nets. Int J Infect Dis (2017) 0.75
Assessing endgame strategies for the elimination of lymphatic filariasis: A model-based evaluation of the impact of DEC-medicated salt. Sci Rep (2017) 0.75
Mass treatment to eliminate filariasis in Papua New Guinea. N Engl J Med (2002) 4.23
Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med (2002) 3.29
A systematic review of mathematical models of mosquito-borne pathogen transmission: 1970-2010. J R Soc Interface (2013) 2.14
Modeling the effects of weather and climate change on malaria transmission. Environ Health Perspect (2010) 2.14
Mathematical modelling and the control of lymphatic filariasis. Lancet Infect Dis (2004) 2.13
Role of vector control in the global program to eliminate lymphatic filariasis. Annu Rev Entomol (2009) 2.13
Why do we need to know more about mixed Plasmodium species infections in humans? Trends Parasitol (2004) 1.98
Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis. Am J Trop Med Hyg (2006) 1.93
Is the current decline in malaria burden in sub-Saharan Africa due to a decrease in vector population? Malar J (2011) 1.91
The role of animal models for research on severe malaria. PLoS Pathog (2012) 1.76
The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea. PLoS Negl Trop Dis (2008) 1.74
Malaria infections are randomly distributed in diverse holoendemic areas of Papua New Guinea. Am J Trop Med Hyg (2002) 1.73
Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. Am J Trop Med Hyg (2008) 1.70
Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection. Am J Trop Med Hyg (2005) 1.70
Climate change epidemiology: methodological challenges. Int J Public Health (2009) 1.57
Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother (2008) 1.50
Insecticidal bed nets and filariasis transmission in Papua New Guinea. N Engl J Med (2013) 1.48
Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults. PLoS One (2008) 1.46
Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes. PLoS One (2007) 1.45
Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM. J Immunol (2007) 1.44
Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis (2007) 1.39
Mathematical models and lymphatic filariasis control: endpoints and optimal interventions. Trends Parasitol (2006) 1.39
Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis. BMC Biol (2010) 1.38
The role of monitoring mosquito infection in the Global Programme to Eliminate Lymphatic Filariasis. Trends Parasitol (2009) 1.33
Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus. J Immunol (2002) 1.32
Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. J Infect Dis (2008) 1.32
Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis. PLoS One (2008) 1.31
Prenatal T cell immunity to Wuchereria bancrofti and its effect on filarial immunity and infection susceptibility during childhood. J Infect Dis (2006) 1.31
Incidence, risk factors and clinical epidemiology of melioidosis: a complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia. BMC Infect Dis (2010) 1.31
Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of Kenya. Infect Immun (2003) 1.29
Measuring the efficacy of insecticide treated bednets: the use of DNA fingerprinting to increase the accuracy of personal protection estimates in Tanzania. Trop Med Int Health (2004) 1.28
Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria. Infect Immun (2004) 1.27
Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands. Infect Immun (2005) 1.26
Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation. Am J Trop Med Hyg (2008) 1.25
Bancroftian filariasis infection, disease, and specific antibody response patterns in a high and a low endemicity community in East Africa. Am J Trop Med Hyg (2002) 1.23
Recasting the theory of mosquito-borne pathogen transmission dynamics and control. Trans R Soc Trop Med Hyg (2014) 1.21
Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions. Trends Parasitol (2006) 1.20
Predicting the current and future potential distributions of lymphatic filariasis in Africa using maximum entropy ecological niche modelling. PLoS One (2012) 1.19
Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission. Infect Immun (2008) 1.17
The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity. Am J Trop Med Hyg (2004) 1.17
Influence of maternal filariasis on childhood infection and immunity to Wuchereria bancrofti in Kenya. Infect Immun (2003) 1.12
Modeling the role of environmental variables on the population dynamics of the malaria vector Anopheles gambiae sensu stricto. Malar J (2012) 1.12
Global eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmes. PLoS One (2008) 1.08
Prenatal malaria immune experience affects acquisition of Plasmodium falciparum merozoite surface protein-1 invasion inhibitory antibodies during infancy. J Immunol (2006) 1.07
A polymerase chain reaction/ligase detection reaction fluorescent microsphere assay to determine Plasmodium falciparum MSP-119 haplotypes. Am J Trop Med Hyg (2007) 1.05
The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania. Trans R Soc Trop Med Hyg (2004) 1.05
Spatial variation of Anopheles-transmitted Wuchereria bancrofti and Plasmodium falciparum infection densities in Papua New Guinea. Filaria J (2003) 1.04
Lymphocyte proliferation and antibody responses to Plasmodium falciparum liver-stage antigen-1 in a highland area of Kenya with seasonal variation in malaria transmission. Am J Trop Med Hyg (2002) 1.04
Modelling climate change and malaria transmission. Adv Exp Med Biol (2010) 1.04
The role of environmental variables on Aedes albopictus biology and chikungunya epidemiology. Pathog Glob Health (2013) 1.03
Lymphatic filariasis in Papua New Guinea: prospects for elimination. Med Microbiol Immunol (2002) 1.03
Glycophorin C (Gerbich antigen blood group) and band 3 polymorphisms in two malaria holoendemic regions of Papua New Guinea. Am J Hematol (2004) 1.03
The complete mitochondrial genome sequence of the filarial nematode Wuchereria bancrofti from three geographic isolates provides evidence of complex demographic history. Mol Biochem Parasitol (2012) 1.03
Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen-1 and thrombospondin-related adhesive protein in residents of a malaria holoendemic area. Am J Trop Med Hyg (2006) 1.01
Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria. Pediatr Infect Dis J (2011) 1.01
Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults. Malar J (2009) 1.00
TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria. Am J Trop Med Hyg (2010) 1.00
Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1. PLoS One (2011) 1.00
Antibodies to Plasmodium falciparum antigens vary by age and antigen in children in a malaria-holoendemic area of Kenya. Pediatr Infect Dis J (2005) 0.99
Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites. J Infect Dis (2013) 0.99
The dynamics of naturally acquired immunity to Plasmodium falciparum infection. PLoS Comput Biol (2012) 0.97
Human bancroftian filariasis: immunological markers of morbidity and infection. Microbes Infect (2006) 0.96
Mapping, bayesian geostatistical analysis and spatial prediction of lymphatic filariasis prevalence in Africa. PLoS One (2013) 0.94
Molecular-based assay for simultaneous detection of four Plasmodium spp. and Wuchereria bancrofti infections. Am J Trop Med Hyg (2010) 0.94
Epidemiological modelling for monitoring and evaluation of lymphatic filariasis control. Adv Parasitol (2007) 0.93
Back to the future: the American Society of Tropical Medicine and Hygiene, its journal and the continuing commitment to global health. Am J Trop Med Hyg (2011) 0.93
Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines. Proc Biol Sci (2010) 0.92
Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea. Am J Trop Med Hyg (2007) 0.91
Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and thrombospondin-related adhesive protein immunodominant epitopes in a highland population from Western Kenya. Am J Trop Med Hyg (2009) 0.89
Erythrocyte polymorphisms and malaria parasite invasion in Papua New Guinea. Trends Parasitol (2003) 0.89
Allele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria. Infect Immun (2010) 0.89
Toll-like receptor polymorphisms in malaria-endemic populations. Malar J (2009) 0.87
Advances in Rift Valley fever research: insights for disease prevention. Curr Opin Infect Dis (2010) 0.87
Modelling co-infection with malaria and lymphatic filariasis. PLoS Comput Biol (2013) 0.87
Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea. PLoS Negl Trop Dis (2011) 0.86
Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea. PLoS One (2013) 0.85
The effect of eight half-yearly single-dose treatments with DEC on Wuchereria bancrofti circulating antigenaemia. Trans R Soc Trop Med Hyg (2005) 0.85
Multiplex assay for species identification and monitoring of insecticide resistance in Anopheles punctulatus group populations of Papua New Guinea. Am J Trop Med Hyg (2012) 0.82
Decreased growth rate of P. falciparum blood stage parasitemia with age in a holoendemic population. J Infect Dis (2013) 0.82
Toll-like receptor polymorphisms and cerebral malaria: TLR2 Δ22 polymorphism is associated with protection from cerebral malaria in a case control study. Malar J (2012) 0.82
Broadly reactive antibodies specific for Plasmodium falciparum MSP-1(19) are associated with the protection of naturally exposed children against infection. Malar J (2012) 0.81
Filarial-specific antibody response in East African bancroftian filariasis: effects of host infection, clinical disease, and filarial endemicity. Am J Trop Med Hyg (2006) 0.79
Time-to-infection by Plasmodium falciparum is largely determined by random factors. BMC Med (2015) 0.79
Population genetics of the filarial worm wuchereria bancrofti in a post-treatment region of Papua New Guinea: insights into diversity and life history. PLoS Negl Trop Dis (2013) 0.78
Density-dependent blood stage Plasmodium falciparum suppresses malaria super-infection in a malaria holoendemic population. Am J Trop Med Hyg (2013) 0.78
Immunoepidemiology of Wuchereria bancrofti infection: parasite transmission intensity, filaria-specific antibodies, and host immunity in two East African communities. Infect Immun (2007) 0.78
Filaria dance sign and subclinical hydrocoele in two east African communities with bancroftian filariasis. Trans R Soc Trop Med Hyg (2003) 0.78
Malaria vaccines: into a mirror, darkly? Trends Parasitol (2008) 0.77
Higher-dose, more frequent treatment of Wuchereria bancrofti. Clin Infect Dis (2010) 0.77
Sensitivity and specificity of ultrasound detection and risk factors for filarial-associated hydroceles. Am J Trop Med Hyg (2003) 0.77
Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia. Southeast Asian J Trop Med Public Health (2014) 0.76
Elimination of lymphatic filariasis. Lancet (2006) 0.76
Temporal epidemiology of microfilaraemia among migrant workers entering Kuwait. BMC Res Notes (2008) 0.75
Immunoepidemiology of Wuchereria bancrofti infection in two East African communities: antibodies to the microfilarial sheath and their role in regulating host microfilaraemia. Acta Trop (2008) 0.75
Concomitant parasitism: bancroftian filariasis and intestinal helminths and response to albendazole. Am J Trop Med Hyg (2005) 0.75